{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:25Z","timestamp":1792181725809,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajg.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:36:09Z","timestamp":1773635769000},"page":"265-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Three decades of change: schistosomiasis, hepatitis C, and the rise of metabolic dysfunction-associated steatotic liver disease in Egypt"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-6894","authenticated-orcid":false,"given":"Mohamed","family":"El-Kassas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.02.005_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s43066-024-00339-2","article-title":"Strategies and achievements in controlling and eliminating schistosomiasis from Egypt","volume":"14","author":"El-Kassas","year":"2024","journal-title":"Egypt Liver J"},{"issue":"9207","key":"10.1016\/j.ajg.2026.02.005_b0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajg.2026.02.005_b0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jvh.12668","article-title":"National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care","volume":"24","author":"El-Akel","year":"2017","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.ajg.2026.02.005_b0020","first-page":"877","article-title":"The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve \u201cgold tier\u201d in conquering the disease","volume":"37","author":"Abosheaishaa","year":"2024","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"10.1016\/j.ajg.2026.02.005_b0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.005_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cld.2023.01.014","article-title":"Nonalcoholic fatty liver disease in Asia, Africa, and Middle East region","volume":"27","author":"Ong","year":"2023","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.005_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/a-1862-9088","article-title":"Nonalcoholic fatty liver disease: current global burden","volume":"42","author":"El-Kassas","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajg.2026.02.005_b0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2334-13-288","article-title":"The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis","volume":"13","author":"Mohamoud","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajg.2026.02.005_b0045","series-title":"Egypt Demographic and Health Survey 2008","author":"El-Zanaty","year":"2009"},{"issue":"5","key":"10.1016\/j.ajg.2026.02.005_b0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21173","article-title":"Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors","volume":"43","author":"Strickland","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ajg.2026.02.005_b0055","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4251\/wjgo.v13.i12.1919","article-title":"Unique situation of hepatocellular carcinoma in Egypt: a review of epidemiology and control measures","volume":"13","author":"Ezzat","year":"2021","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.ajg.2026.02.005_b0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s005350170017","article-title":"Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect","volume":"36","author":"Gad","year":"2001","journal-title":"J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ajg.2026.02.005_b0065","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1002\/jmv.27165","article-title":"Hepatitis C virus genotype 4: a poorly characterized endemic genotype","volume":"93","author":"Leumi","year":"2021","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"10.1016\/j.ajg.2026.02.005_b0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/liv.12397","article-title":"Optimizing treatment for HCV genotype 4: PEG-IFN alfa-2a vs. PEG-IFN alfa-2b","volume":"34","author":"Esmat","year":"2014","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.ajg.2026.02.005_b0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14787210.2020.1758065","article-title":"Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt","volume":"18","author":"Esmat","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.005_b0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2025.01.013","article-title":"Number of people treated for hepatitis C virus infection in 2014\u20132023 and applicable lessons for new HBV and HDV therapies","volume":"83","author":"Polaris Observatory Collaborators","year":"2025","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ajg.2026.02.005_b0085","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1080\/14740338.2017.1240781","article-title":"Safety of direct antiviral agents in the management of hepatitis C","volume":"15","author":"El-Kassas","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.005_b0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jare.2014.11.004","article-title":"New era for management of chronic hepatitis C virus using direct antiviral agents: a review","volume":"6","author":"Elbaz","year":"2015","journal-title":"J Adv Res"},{"issue":"4","key":"10.1016\/j.ajg.2026.02.005_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14787210.2018.1448709","article-title":"HCV in Egypt, prevention, treatment and key barriers to elimination","volume":"16","author":"El Kassas","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.005_b0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/jvh.13778","article-title":"Hepatocellular carcinoma and hepatitis C virus treatments: the bold and the beautiful","volume":"30","author":"Abdelhamed","year":"2023","journal-title":"J Viral Hepat"},{"issue":"45","key":"10.1016\/j.ajg.2026.02.005_b0105","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i45.111643","article-title":"Metabolic dysfunction-associated steatotic liver disease in Egypt: epidemiology, risk factors and management challenges","volume":"31","author":"Abdelhamed","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.005_b0110","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2024","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.ajg.2026.02.005_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70342","article-title":"Two-decade trends in MASLD and its complications in the Middle East and North Africa (2010\u20132021)","volume":"45","author":"Younossi","year":"2025","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.ajg.2026.02.005_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70108","article-title":"Metabolic dysfunction-associated steatotic liver disease in the MENA region: setting a research and action priority agenda","volume":"45","author":"El-Kassas","year":"2025","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ajg.2026.02.005_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/sjg.sjg_247_25","article-title":"Economic and clinical implications of metabolic dysfunction-associated steatotic liver disease management: regional challenges and opportunities in Middle East and North Africa","volume":"31","author":"El-Kassas","year":"2025","journal-title":"Saudi J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ajg.2026.02.005_b0130","first-page":"791","article-title":"Mapping metabolic dysfunction-associated steatotic liver disease models of care across 17 middle east and north AFRICA countries: insights into guidelines, infrastructure, and referral systems","volume":"13","author":"El-Kassas","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ajg.2026.02.005_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43066-025-00431-1","article-title":"Prevalence, risk factors, quality of life, and awareness of MASLD among Egyptian university students","volume":"15","author":"El-Kassas","year":"2025","journal-title":"Egypt Liver J"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.005_b0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajg.2019.05.004","article-title":"Egyptian liver library: an indexed database for liver-disease evidence in Egypt","volume":"20","author":"Alboraie","year":"2019","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.ajg.2026.02.005_b0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43066-024-00326-7","article-title":"Obesity prevalence in adults and patients with hepatitis C: results from screening a population of 50 million in Egypt","volume":"14","author":"Esmat","year":"2024","journal-title":"Egypt Liver J"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719792600033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719792600033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:26:46Z","timestamp":1787124406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168719792600033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S168719792600033X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.02.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three decades of change: schistosomiasis, hepatitis C, and the rise of metabolic dysfunction-associated steatotic liver disease in Egypt","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}